Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation

被引：0
|
作者：
Matthew C. Dickson
Michael M. Nguyen
Charmi Patel
Shannon C. Grabich
Carmela Benson
Terry Cothran
Grant H. Skrepnek
机构：
[1] The University of Oklahoma Health Sciences Center,College of Pharmacy
[2] Janssen Scientific Affairs,undefined
[3] LLC,undefined
[4] Xcenda,undefined
[5] LLC,undefined
[6] Oklahoma Health Care Authority,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Adherence; Costs; Machine learning; Medication switches; Oral antipsychotics; Paliperidone palmitate; Persistence; Readmissions; Schizoaffective disorder; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 366
页数：17
相关论文
共 15 条
  • [1] Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation
    Dickson, Matthew C.
    Nguyen, Michael M.
    Patel, Charmi
    Grabich, Shannon C.
    Benson, Carmela
    Cothran, Terry
    Skrepnek, Grant H.
    ADVANCES IN THERAPY, 2023, 40 (01) : 349 - 366
  • [2] Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits
    Joshi, Kruti
    Lafeuille, Marie-Helene
    Kamstra, Rhiannon
    Tiggelaar, Sean
    Lefebvre, Patrick
    Kim, Edward
    Yue, Yong
    Tandon, Neeta
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (02) : 121 - 133
  • [3] Once-monthly paliperidone palmitate versus daily oral antipsychotics delays adverse real-world consequences of schizophrenia
    Starr, H.
    Mao, L.
    Rodriguez, S.
    Alphs, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S550 - S551
  • [4] HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH PALIPERIDONE PALMITATE VERSUS ORAL ATYPICAL ANTIPSYCHOTICS AMONG PATIENTS WITH SCHIZOAFFECTIVE DISORDER
    Pesa, J. A.
    Muser, E.
    Montejano, L. B.
    Kim, G.
    Smith, D. M.
    VALUE IN HEALTH, 2015, 18 (03) : A118 - A119
  • [5] Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
    Charmi Patel
    Bruno Emond
    Marie-Hélène Lafeuille
    Aurélie Côté-Sergent
    Patrick Lefebvre
    Neeta Tandon
    Antoine C. El Khoury
    Drugs - Real World Outcomes, 2020, 7 : 19 - 29
  • [6] Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
    Patel, Charmi
    Emond, Bruno
    Lafeuille, Marie-Helene
    Cote-Sergent, Aurelie
    Lefebvre, Patrick
    Tandon, Neeta
    El Khoury, Antoine C.
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (01) : 19 - 29
  • [7] Persistence and adherence of long acting injectable paliperidone palmitate vs oral atypical antipsychotics for schizophrenia treatment: a retrospective cohort study in china
    Wu, W.
    Wu, T.
    Zhang, L.
    Zhang, Y.
    Si, T.
    Dong, W.
    EUROPEAN PSYCHIATRY, 2020, 63 : S144 - S144
  • [8] Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
    Lita Araujo
    Svend S. Geertsen
    Allen Amedume
    Keiko Higuchi
    Janneke van Wingerden
    Neurology and Therapy, 2022, 11 : 1735 - 1748
  • [9] Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
    Araujo, Lita
    Geertsen, Svend S.
    Amedume, Allen
    Higuchi, Keiko
    van Wingerden, Janneke
    NEUROLOGY AND THERAPY, 2022, 11 (04) : 1735 - 1748
  • [10] Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong
    Choon, June W. Y.
    Wu, David B. C.
    Chong, H. Y.
    Lo, William T. L.
    Chong, Catherine S. Y.
    Chung, W. S.
    Chui, Eileena M. C.
    Tomlinson, Brian
    Lee, Vivian W. Y.
    Lee, S. C.
    Lee, Kenneth K. C.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (03) : 273 - 279
12